Like copyright, Wegovy has the active component semaglutide. The principle difference between The 2 is always that copyright is at present approved for Form 2 diabetic issues and kidney condition, and Wegovy is currently permitted for bodyweight administration. (Each are permitted for cardiovascular threat reduction.) This could complicate insuranc